Pharmaceutical

Kura Oncology partners Kyowa Kirin to advance AML treatment

Kura has partnered Kyowa Kirin in a strategic global collaboration for developing and commercialising oral ziftomenib to treat AML

Nov 21, 2024 - 06:00
Kura Oncology partners Kyowa Kirin to advance AML treatment
Kura has partnered Kyowa Kirin in a strategic global collaboration for developing and commercialising oral ziftomenib to treat AML
Read the original article

Tags:

Previous Article

Roche Partners with Transcription Factor Pioneer Flare in over $1.8B Cancer Deal

Next Article

EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: How the twin crises of climate change and poor public housing are harming people’s health

Opinion: How the twin crises of climate change and poor...

Aug 29, 2023

STAT+: Why doesn’t everyone lose weight on Ozempic-type drugs? Researchers look for genetic clues

STAT+: Why doesn’t everyone lose weight on Ozempic-type...

Oct 18, 2023

US Justice Dept cracks down on healthcare fraud schemes linked to $2.75bn loss

US Justice Dept cracks down on healthcare fraud schemes...

Jun 30, 2024